Biotechnology
Polish companies specializing in biotechnology
Biotechnology firms research and develop new medical therapies or agricultural processes. Clinical trial outcomes and regulatory decisions routinely drive extreme price action and liquidity across this industry. Currently, QNA Technology SA ranks as the top gainer, and MultiQure S.A. sees maximum volume. The technical and fundamental metrics provided below help quantify these sudden shifts.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 MQRMultiQure S.A. | 316.5 M PLN | 1.396 PLN | +0.58% | 96.12 K | 0.27 | — | −12.81 PLN | −552.86% | 0.00% | Health technology | No rating |
 SLVSelvita SA | 294.05 M PLN | 16.36 PLN | −0.24% | 39.84 K | 0.64 | — | −0.11 PLN | −548.22% | 0.00% | Health technology | Buy |
 MABMabion SA | 126.07 M PLN | 7.72 PLN | −1.03% | 11.86 K | 0.61 | — | −3.50 PLN | +12.68% | 0.00% | Health technology | No rating |
 QNAQNA Technology SA | 96.31 M PLN | 30.6 PLN | +1.66% | 3.05 K | 2.19 | — | — | — | — | Health technology | Strong buy |
 RDGRead-Gene SA | 57.54 M PLN | 4.88 PLN | 0.00% | 72 | 0.49 | 47.01 | 0.10 PLN | — | 0.00% | Health technology | No rating |
 GX1genXone SA | 16.39 M PLN | 4.50 PLN | −6.25% | 2.27 K | 5.17 | — | −0.51 PLN | +52.36% | 0.00% | Health technology | No rating |
 RNTPrivate Rented Sector S.A. | 7.52 M PLN | 5.50 PLN | 0.00% | 0 | — | — | — | — | 0.00% | Health technology | No rating |
 ADVAdiuvo Investment S.A. | 7.27 M PLN | 0.542 PLN | −4.91% | 23 | 0.00 | — | — | — | 0.00% | Health technology | No rating |